Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation

[1]  A. Gratwohl,et al.  Blood and marrow transplantation activity in Europe 1997 , 1999, Bone Marrow Transplantation.

[2]  J. Clive,et al.  Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance , 1999, Bone Marrow Transplantation.

[3]  K. Takenaka,et al.  Early viral complications following CD34‐selected autologous peripheral blood stem cell transplantation for non‐Hodgkin's lymphoma , 1998, British journal of haematology.

[4]  L. Young,et al.  1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Hainsworth,et al.  Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers , 1997, Bone Marrow Transplantation.

[6]  A. Gratwohl,et al.  Blood and marrow transplantation activity in Europe 1995 , 1997, Bone Marrow Transplantation.

[7]  J. Perfect,et al.  Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  W. Hiddemann,et al.  [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society]. , 1994, Medizinische Klinik.

[9]  P. Pizzo,et al.  Management of fever in patients with cancer and treatment-induced neutropenia. , 1993, The New England journal of medicine.

[10]  M. Pfaller,et al.  Molecular Epidemiology of Coagulase-Negative Staphylococci Isolated From Immunocompromised Patients , 1992, Infection Control & Hospital Epidemiology.

[11]  J. Meyers.  Infection in bone marrow transplant recipients. , 1986, The American journal of medicine.

[12]  R. Salazar,et al.  Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation , 1999, Bone Marrow Transplantation.

[13]  C. Huber,et al.  Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation , 1997, Bone Marrow Transplantation.